Chronic pain affects 70 million American and its cost to the US economy is over $150 billion per annum. A critical first step in the design of innovative treatments for chronic pain is the development of new methods to evaluate pain and the cerebral "signature" for its perception and modulation, and in so doing, be able to monitor the effect of new therapies on pain in an objective fashion.